Mirum Pharmaceuticals logo

Mirum Pharmaceuticals share price today

(MIRM)

Mirum Pharmaceuticals share price is $42.17 & ₹3,591.16 as on 25 Dec 2024, 2.30 'hrs' IST

$42.17

0.44

(1.05%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Mirum Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Mirum Pharmaceuticals from India. Also see the sentimental analysis on Indian investors investing in Mirum Pharmaceuticals. Get details on the Indian mutual funds that are investing in Mirum Pharmaceuticals. Get Analyst recommendations and forecasts along with all the Mirum Pharmaceuticals's financials.

Mirum Pharmaceuticals share price movements

  • Today's Low: $41.22
    Today's High: $42.47

    Day's Volatility :2.93%

  • 52 Weeks Low: $23.14
    52 Weeks High: $48.89

    52 Weeks Volatility :52.67%

Mirum Pharmaceuticals Returns

PeriodMirum Pharmaceuticals IncSector (Health Care)Index (Russel 2000)
3 Months
7.03%
-10.0%
0.0%
6 Months
26.99%
-5.7%
0.0%
1 Year
37.95%
2.8%
0.0%
3 Years
166.14%
-0.4%
-21.1%

Mirum Pharmaceuticals Key Statistics

in dollars & INR

Previous Close
$41.73
Open
$41.87
Today's High
$42.465
Today's Low
$41.22
Market Capitalization
$2.0B
Today's Volume
$320.1K
52 Week High
$48.89
52 Week Low
$23.14
Revenue TTM
$307.0M
EBITDA
$-72.9M
Earnings Per Share (EPS)
$-2.08
Profit Margin
-32.51%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-39.84%

How to invest in Mirum Pharmaceuticals from India?

It is very easy for Indian residents to invest directly in Mirum Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Mirum Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Mirum Pharmaceuticals or MIRM on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Mirum Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Mirum Pharmaceuticals shares which would translate to 0.020 fractional shares of Mirum Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Mirum Pharmaceuticals, in just a few clicks!

Returns in Mirum Pharmaceuticals for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Mirum Pharmaceuticals investment value today

Current value as on today

₹1,41,804

Returns

₹41,804

(+41.8%)

Returns from Mirum Pharmaceuticals Stock

₹39,405 (+39.4%)

Dollar Returns

₹2,399 (+2.4%)

Indian investors sentiment towards Mirum Pharmaceuticals

-75%

Period: Sep 25, 2024 to Dec 24, 2024. Change in 30 Days versus previous period

Search volume for Mirum Pharmaceuticals on INDmoney from India has reduced in the last 30 days as on Dec 25, 2024. -75% less investors are searching Mirum Pharmaceuticals in the last 30 days versus the previous period.

Global Institutional Holdings in Mirum Pharmaceuticals

  • HHG PLC

    9.33%

  • Eventide Asset Management, LLC

    7.18%

  • BlackRock Inc

    6.75%

  • Bvf Inc

    6.41%

  • Vanguard Group Inc

    5.20%

  • State Street Corp

    3.74%

Analyst Recommendation on Mirum Pharmaceuticals

Buy

    94%Buy

    5%Hold

    0%Sell

Based on 17 Wall street analysts offering stock ratings for Mirum Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 17 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
16
15
15
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Mirum Pharmaceuticals

What analysts predicted

Upside of 49.4%

Current:

$42.17

Target:

$63.00

Insights on Mirum Pharmaceuticals

  • Price Movement

    In the last 3 years, MIRM stock has moved up by 167.5%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 69.22M → 90.37M (in $), with an average increase of 12.5% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 4 quarters, -33.14M → -14.23M (in $), with an average increase of 35.6% per quarter

Mirum Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Mirum Pharmaceuticals is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Mirum Pharmaceuticals Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Mirum Pharmaceuticals Inc
-5.74%
26.99%
37.95%
166.14%
61.12%
Regeneron Pharmaceuticals, Inc.
-4.59%
-33.11%
-15.82%
12.66%
91.56%
Biontech Se
-6.0%
37.55%
8.38%
-55.46%
248.4%
Alnylam Pharmaceuticals, Inc.
-3.47%
-1.19%
26.71%
50.37%
106.11%
Vertex Pharmaceuticals Incorporated
-12.22%
-14.5%
-0.59%
82.27%
83.4%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Mirum Pharmaceuticals Inc
NA
NA
NA
-1.48
-0.4
-0.09
NA
4.84
Regeneron Pharmaceuticals, Inc.
17.36
17.36
1.04
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.04
0.54
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Mirum Pharmaceuticals Inc
Buy
$2.0B
61.12%
NA
-32.51%
Regeneron Pharmaceuticals, Inc.
Buy
$77.1B
91.56%
17.36
33.61%
Biontech Se
Buy
$27.1B
248.4%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$31.7B
106.11%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$102.3B
83.4%
32.84
-4.51%

Mirum Pharmaceuticals Dividend announcements

  • Mirum Pharmaceuticals Earnings

    Mirum Pharmaceuticals’s price-to-earnings ratio stands at None

    Read More

About Mirum Pharmaceuticals

mirum pharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. its lead product candidate is maralixibat, an investigational oral drug that is in phase 3 clinical trial for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of alagille syndrome and biliary atresia disease. the company is also develops volixibat drug for treatment of intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. mirum pharmaceuticals, inc. was founded in 2018 and is headquartered in foster city, california.
Organization
Mirum Pharmaceuticals
Employees
311
CEO
Mr. Christopher Peetz
Industry
Health Technology

Management People of Mirum Pharmaceuticals

NameTitle
Mr. Christopher Peetz
CEO & Director
Mr. Peter Radovich M.B.A., Ph.D.
COO & President
Mr. Eric H. Bjerkholt M.B.A.
Chief Financial Officer
Dr. Pamela Vig Ph.D.
Chief Scientific Officer
Andrew McKibben
Vice President of Investor Relations and Finance
Mr. Paul K. Ross
Chief Compliance Officer
Ms. Erin Campany
Senior Vice President of Human Resources
Ms. Lara Longpre MBA, MSC
Chief Development Officer
Ms. Vinita P. Kumar
Senior vice President of Quality
Dr. Jean-Luc Girardet Ph.D.
Senior Vice President of Technical Operations

Important FAQs about investing in Mirum Pharmaceuticals from India :

What is Mirum Pharmaceuticals share price today?

Mirum Pharmaceuticals share price today stands at $42.17, Open: $41.87 ; Previous Close: $41.73 ; High: $42.47 ; Low: $41.22 ; 52 Week High: $48.89 ; 52 Week Low: $23.14. The stock opens at $41.87, after a previous close of $41.73. The stock reached a daily high of $42.47 and a low of $41.22, with a 52-week high of $48.89 and a 52-week low of $23.14.

Can Indians buy Mirum Pharmaceuticals shares?

Yes, Indians can invest in the Mirum Pharmaceuticals (MIRM) from India.

With INDmoney, you can buy Mirum Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Mirum Pharmaceuticals at zero transaction cost.

How can I buy Mirum Pharmaceuticals shares from India?

It is very easy to buy Mirum Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Mirum Pharmaceuticals be purchased?

Yes, you can buy fractional shares of Mirum Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Mirum Pharmaceuticals stocks?

To start investing in Mirum Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Mirum Pharmaceuticals

Today’s highest price of Mirum Pharmaceuticals (MIRM) is $42.47.

Today’s lowest price of Mirum Pharmaceuticals (MIRM) is $41.22.

What is today's market capitalisation of Mirum Pharmaceuticals

Today's market capitalisation of Mirum Pharmaceuticals MIRM is 2.0B

What is the 52 Week High and Low Range of Mirum Pharmaceuticals

  • 52 Week High

    $48.89

  • 52 Week Low

    $23.14

What are the historical returns of Mirum Pharmaceuticals?

  • 1 Month Returns

    -5.74%

  • 3 Months Returns

    26.99%

  • 1 Year Returns

    37.95%

  • 5 Years Returns

    61.12%

Who is the Chief Executive Officer (CEO) of Mirum Pharmaceuticals

Mr. Christopher Peetz is the current Chief Executive Officer (CEO) of Mirum Pharmaceuticals.